Cargando…

A rare case of esophageal metastasis from pancreatic ductal adenocarcinoma: a case report and literature review

PURPOSE: We report a very unique case of an esophageal metastasis from a pancreatic ductal adenocarcinoma (PDAC) primary. METHODS: After obtaining consent from the patient, all relevant records of the case were obtained and retrospectively reviewed. RESULTS: At presentation, the patient was diagnose...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosati, Lauren M., Kummerlowe, Megan N., Poling, Justin, Hacker-Prietz, Amy, Narang, Amol K., Shin, Eun J., Le, Dung T., Fishman, Elliot K., Hruban, Ralph H., Yang, Stephen C., Weiss, Matthew J., Herman, Joseph M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725074/ https://www.ncbi.nlm.nih.gov/pubmed/29246032 http://dx.doi.org/10.18632/oncotarget.18458

Ejemplares similares

Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity
por: Hill, Colin S., et al.
Publicado: (2022)

An unusual genomic variant of pancreatic ductal adenocarcinoma with an indolent clinical course
por: Kohutek, Zachary A., et al.
Publicado: (2017)

Molecular Characteristics of Pancreatic Ductal Adenocarcinoma
por: Ottenhof, Niki A., et al.
Publicado: (2011)

Long‐term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancer
por: Shrestha, Bikram, et al.
Publicado: (2017)

Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinoma
por: Jia, Angela Y., et al.
Publicado: (2019)

Resected pancreatic ductal adenocarcinomas with recurrence limited in lung have a significantly better prognosis than those with other recurrence patterns
por: Wangjam, Tamna, et al.
Publicado: (2015)

Adult Pancreatic Hemangioma: Case Report and Literature Review
por: Mundinger, Gerhard S., et al.
Publicado: (2009)

Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant chemotherapy and stereotactic body radiotherapy followed by surgical resection
por: Reddy, Abhinav V., et al.
Publicado: (2021)

Surgical management of giant Brunner's gland hamartoma: case report and literature review
por: Stewart, Zoe A, et al.
Publicado: (2009)

Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas
por: Handra-Luca, A, et al.
Publicado: (2011)

What Advanced Practitioners Need to Know About the Diagnosis and Treatment of Patients With Pancreatic Cancer
por: Herman, Joseph M., et al.
Publicado: (2017)

Stereotactic body radiation therapy for palliative management of pancreatic adenocarcinoma in elderly and medically inoperable patients
por: Ryan, John F., et al.
Publicado: (2018)

Improving prediction of surgical resectability over current staging guidelines in patients with pancreatic cancer who receive stereotactic body radiation therapy
por: Cheng, Zhi, et al.
Publicado: (2018)

Obstructive Sleep Apnea and Pathological Characteristics of Resected Pancreatic Ductal Adenocarcinoma
por: Dal Molin, Marco, et al.
Publicado: (2016)

Colonic Endometriosis Mimicking Colon Cancer on a Virtual Colonoscopy Study: A Potential Pitfall in Diagnosis
por: Samet, Jonathan D., et al.
Publicado: (2009)

Glomus Tumor of the Stomach: Depiction by Multidetector CT and Three-Dimensional Volume Rendering Imaging
por: Patel, Tarak H., et al.
Publicado: (2010)

Retrotransposon insertions in the clonal evolution of pancreatic ductal adenocarcinoma
por: Rodić, Nemanja, et al.
Publicado: (2015)

High local failure rates despite high margin‐negative resection rates in a cohort of borderline resectable and locally advanced pancreatic cancer patients treated with stereotactic body radiation therapy following multi‐agent chemotherapy
por: Hill, Colin, et al.
Publicado: (2022)

The Impact of the COVID-19 Pandemic on Multidisciplinary Clinics: A High-Volume Pancreatic Cancer Center Experience
por: Javed, Ammar A., et al.
Publicado: (2022)

Ductal Adenocarcinoma of the Prostate: A Case Report
por: Hayashi, Yutaro, et al.
Publicado: (2016)

Long-term analysis of 2 prospective studies that incorporate mitomycin C into an adjuvant chemoradiation regimen for pancreatic and periampullary cancers
por: Schunke, Kathryn J., et al.
Publicado: (2017)

Anatomic Criteria Determine Resectability in Locally Advanced Pancreatic Cancer
por: Gemenetzis, Georgios, et al.
Publicado: (2021)

Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital - Mayo Clinic collaborative study
por: Narang, Amol K, et al.
Publicado: (2011)

Two cases of pancreatic ductal adenocarcinoma with intrapancreatic metastasis
por: Fujita, Yusuke, et al.
Publicado: (2016)

Case report of prostate ductal adenocarcinoma presenting with hematuria
por: Pawlowski, Jamie, et al.
Publicado: (2018)

Cancerization of the Pancreatic Ducts: Demonstration of a Common and Under-recognized Process Using Immunolabeling of Paired Duct Lesions and Invasive Pancreatic Ductal Adenocarcinoma for p53 and Smad4 Expression
por: Hutchings, Danielle, et al.
Publicado: (2018)

Disruption of p16 and Activation of Kras in Pancreas Increase Ductal Adenocarcinoma Formation and Metastasis in vivo
por: Qiu, Wanglong, et al.
Publicado: (2011)

Telomeres are shortened in acinar-to-ductal metaplasia lesions associated with pancreatic intraepithelial neoplasia but not in isolated acinar-to-ductal metaplasias
por: Hong, Seung-Mo, et al.
Publicado: (2010)

Mimics of pancreatic ductal adenocarcinoma
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Family History of Cancer and Tobacco Exposure in Index Cases of Pancreatic Ductal Adenocarcinoma
por: Lochan, R., et al.
Publicado: (2011)

Resectable adenocarcinoma developing in the remnant pancreas 7 years after partial pancreatoduodenectomy for invasive ductal adenocarcinoma of the pancreas: a case report
por: Frei, Lina, et al.
Publicado: (2017)

The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma
por: Pérez-Mancera, Pedro A., et al.
Publicado: (2012)

Resectable pancreatic small cell carcinoma
por: Winter, Jordan M., et al.
Publicado: (2011)

Gastric adenocarcinoma causing biliary obstruction without ductal dilatation: a case report
por: Vaz, Karl, et al.
Publicado: (2019)

A rare case of giant panda cancer: Pancreatic ductal adenocarcinoma
por: Wang, Yunsheng, et al.
Publicado: (2022)

A case of pancreatic ductal adenocarcinoma with marked infiltration with IgG4-positive cells
por: Yoneda, M, et al.
Publicado: (2013)

Comparison of Radiomic Features in a Diverse Cohort of Patients With Pancreatic Ductal Adenocarcinomas
por: Permuth, Jennifer B., et al.
Publicado: (2021)

Targeted Nanoparticles for Imaging Incipient Pancreatic Ductal Adenocarcinoma
por: Kelly, Kimberly A, et al.
Publicado: (2008)

Pancreatic ductal adenocarcinoma staging
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Syndecans and Pancreatic Ductal Adenocarcinoma
por: Betriu, Nausika, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2bbbtqn52emmuq967ikhi5ik8v